Is ADAG up or down today?
ADAG is down 14.52% today, last at 2.06. This stock moved -14.52% versus the prior close.
ADAG · ADAG
ADAG (ADAG) is trading at 2.06, down 14.52% on the session. ADAG carries a 14-day RSI of 34, and trades below its 50-day average. Over the past month it is down 29.69%.
Leading the coverage: “Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer” (Yahoo Finance, 8d ago). ADAG is -8.91% since story.
ADAG trades on a trailing P/E of 46.5 and is running 24.12% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
ADAG is down 14.52% today, last at 2.06. This stock moved -14.52% versus the prior close.
Leading the coverage: “Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer” (Yahoo Finance, 8d ago). ADAG is -8.91% since story. Dominant story: Adagene Inc. (ADAG) Seasonal returns chart - Yahoo Finance UK (1 source, neutral) RSI is 34 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Adagene Inc. (ADAG) Seasonal returns chart - Yahoo Finance UK
Adagene Inc. (ADAG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Adagene Inc. (ADAG) Earnings Date, Reports and Estimates - Traders Union
Adagene Stock Price Forecast. Should You Buy ADAG? - StockInvest.us
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer